Kids

BBB Industries Announces Rebranding, Changes Name to TERREPOWER

BBB Industries has unveiled a new name and logo to reflect the company\'s growth and commitment to its mission: To spread the power of sustainable manufacturing at scale.

02-06

mF International Limited Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule

HONG KONG,Feb. 4,2025--mF International Limited (the "Company" or "mF International") (Nasdaq: MFI),a Hong Kong-based experienced financial trading solutions provider,today announc

02-06

MAHLE Aftermarket Chooses Getac Rugged Solution to Power New Android-Based Diagnostic Tool

TAIPEI,Feb. 5,2025-- Getac Technology Corporation(Getac),a leading global provider of rugged computing solutions,has joined MAHLE Aftermarket in the development of its new diagnostic tool,which is bu

02-06

Blokees exhibits Multiple IP Series Products at Spielwarenmesse 2025 in Nuremberg

SHANGHAI,Feb. 5,2025-- The Spielwarenmesse International Toy Fair,one of top three toy-specialised trade fairs,has been officially held in Nuremberg from January 28 to February 1,2025. At this sensati

02-06

AI & Genomics Advances Bring New Hope to Lung Cancer Burden in Asia

SINGAPORE,Feb. 5,2025-- Asia is the region most impacted by lung cancer,accounting for 63.1% of newly diagnosed lung cancers and 62.9% of lung cancer deaths worldwide(1).

02-06

Ericsson appoints Charlotte Levert as Chief People Officer

Effective as of February 10,2025 Becomes member of Ericsson\'s Executive Team,reporting to the CEO STOCKHOLM,Feb. 5,2025-- Ericsson (NASDAQ: ERIC) today announces the appointment of Charlotte Levert a

02-06

FDA Clears World's First Mobile App for Contactless Pulse Rate Measurement

PanopticAI\'s tech turns smartphones and tablets into medical-grade vital sign monitors. This is a major milestone in the Hong Kong-based startup\'s mission to ensure accessible,scalable healthcare.

02-06 PanopticAI Limited

Seeking Investors: First-in-Class Immunotherapeutics for Cancer

ATLANTA,Jan. 27,2025-- Cambium Oncology is pleased to share that their lead drug candidate,ANT308,recently demonstrated outstanding single-agent efficacy and safety in preclinical studies. The drug i

02-06 Cambium Oncology

Spiber Inc. announces strategic partnership with Botto Giuseppe and launches 100% Brewed Protein™ yarn for the first time in collaboration with a European mill

YAMAGATA,Japan,Jan. 27,2025-- Spiber,a pioneer in protein fibre (ISO 2076),produced using cutting-edge fermentation technology,is proud to announce its successful partnership with Botto Giuseppe,a pr

02-06 Spiber Inc.

Telix Completes Acquisition of RLS (USA) Inc.

MELBOURNE,Australia and INDIANAPOLIS,Jan. 28,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces it has completed the acquisition of RLS (USA) Inc. (RLS; RLS

02-06 Telix Pharmaceuticals Limited